Investor Relations | Stock Quote / Details | Request Info | News | SEC Filings | Charts | Financials | Video Presentations | Corp. Governance | Profile | Historical Quotes | Disclaimer | Depth / Level II

News

Dr. Myron Wentz Resigns from Immunosyn Board of Directors
Mar 20 2009, 6:22 PM EDT
Immunosyn Corporation Announces 2008 Results
Mar 19 2009, 12:53 PM EDT
Immunosyn Corporation Files 10-Q
Nov 18 2008, 9:00 AM EST
SF-1019 Receives Approval for Treatment, Marketing and Distribution in Malaysia
Aug 12 2008, 9:00 AM EDT
Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah
Jul 16 2008, 9:00 AM EDT
Immunosyn Corporation Files 10-Q
May 16 2008, 6:29 PM EDT
Immunosyn Corporation Announces 2007 Results, Files 10KSB
Mar 31 2008, 3:59 PM EDT
USANA's CEO Myron W. Wentz, Ph.D. Has Been Elected to Serve on Immunosyn Corporation's Board of Directors
Mar 17 2008, 9:00 AM EDT
Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
Feb 26 2008, 9:00 AM EST
Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn
Feb 1 2008, 4:41 PM EST

1
2
3

View Our Corporate Presentation (summary or detailed)

:: Home :: Company :: Vision :: Leadership :: Products :: Awareness :: Alliances :: FAQ :: Contact Us ::

website design copyright 2007 In Joy Marketing